Gene · 246100
Papers4,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PhIP-Seq: unveiling the complexity of antibody repertoires in health and disease. | Front Immunol | 2026 | 41743708 | PubTator, text mining | PubMed |
| Ready or not, here they come: a practical guide to adoptive T-cell therapies for solid tumors for medical oncologists. | Oncologist | 2026 | 41739670 | PubTator, text mining | PubMed |
| Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors. | Small Sci | 2026 | 41737839 | PubTator, text mining | PubMed |
| Reprogramming the immune microenvironment in triple-negative breast cancer with mRNA therapeutics. | Cancer Lett | 2026 | 41730382 | PubTator, text mining | PubMed |
| The double-positive cells in the tumor microenvironment. | J Transl Int Med | 2026 | 41727966 | PubTator, text mining | PubMed |
| Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemias. | Mol Ther Oncol | 2026 | 41716469 | PubTator, text mining | PubMed |
| Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers. | Mol Ther Oncol | 2026 | 41716468 | PubTator, text mining | PubMed |
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
| STAT1 accelerates cutaneous melanoma progression through TUBB4A expression regulation. | Mol Med Rep | 2026 | 41716028 | PubTator, text mining | PubMed |
| Validation of a blood-based autoantibody test to assess lung cancer risk in 4-30 mm pulmonary nodules: a retrospective pooled analysis of four cohort studies. | Future Oncol | 2026 | 41703731 | PubTator, text mining | PubMed |
| CD4+ T cells in cancer: dual roles, exhaustion, and therapeutic breakthroughs. | Cancer Biol Med | 2026 | 41700795 | PubTator, text mining | PubMed |
| The Molecular Mechanism and Therapeutic Progress in Glomus Tumor. | Cancer Med | 2026 | 41693210 | PubTator, text mining | PubMed |
| Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer. | Sci Rep | 2026 | 41663641 | PubTator, text mining | PubMed |
| Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. | Nat Med | 2026 | 41593194 | PubTator, text mining | PubMed |
| Mapping kinase-dependent tumor immune adaptation with multiplexed single-cell CRISPR screens. | bioRxiv | 2026 | 41542636 | PubTator, text mining | PubMed |
| Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy. | Neurooncol Adv | 2026 | 41541220 | PubTator, text mining | PubMed |
| Dark and camouflaged genomic regions remain challenging in CHM13. | Sci Rep | 2026 | 41526367 | PubTator, text mining | PubMed |
| Cell therapy in sarcoma: current landscape and future directions. | J Immunother Cancer | 2026 | 41526168 | PubTator, text mining | PubMed |
| Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. | Nat Med | 2026 | 41482561 | PubTator, text mining | PubMed |
| Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma. | Anticancer Res | 2026 | 41469101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/246100/papers?page=3